Show simple item record

dc.contributor.authorJones, Huw S.
dc.contributor.authorPapageorgiou, M.
dc.contributor.authorGordon, A.
dc.contributor.authorEhtesham
dc.contributor.authorWells, L.K.
dc.contributor.authorJaved, Z.
dc.contributor.authorGreetham, S.
dc.contributor.authorDoyle, B.
dc.contributor.authorHayes, N.
dc.contributor.authorRigby, A.
dc.contributor.authorAtkin, S.L.
dc.contributor.authorCourts, F.L.
dc.contributor.authorSathyapalan, T.
dc.date.accessioned2020-04-29T13:28:33Z
dc.date.accessioned2020-05-11T11:21:49Z
dc.date.available2020-04-29T13:28:33Z
dc.date.available2020-05-11T11:21:49Z
dc.date.issued2020-03
dc.identifier.citationJones HS, Papageorgiou M, Gordon A et al (2020) Physiologically relevant screening of polyphenol-rich commercial preparations for bioactivity in vascular endothelial cells and application to healthy volunteers: A viable workflow and a cautionary tale. Biochemical Pharmacology. 173: 113754.en_US
dc.identifier.urihttp://hdl.handle.net/10454/17791
dc.descriptionYesen_US
dc.description.abstractThis study describes the screening of 13 commercially-available plant extracts for pharmacological activity modulating vascular function using an endothelial cell model. A French maritime pine bark extract (FMPBE) was found to have the greatest effect upon nitric oxide availability in control (181% ± 36% of untreated cells) and dysfunctional cells (132% ± 8% of untreated control cells). In healthy volunteers, the FMPBE increased plasma nitrite concentrations 8 h post-consumption compared to baseline (baseline corrected median 1.71 ± 0.38 (25% IQR) and 4.76 (75% IQR) µM, p < 0.05). This was followed by a placebo-controlled, healthy volunteer study, which showed no effects on plasma nitrite. It was confirmed that different batches of extract had been used in the healthy volunteer studies, and this second batch lacked bioactivity, assessed using the in vitro model. No difference in plasma catechin levels was seen at 8 h following supplementation between the studies (252 ± 194 nM versus 50 ± 64 nM, p > 0.05), however HPLC-UV fingerprinting showed that the new batch had a 5-15% in major constituents (including procyanidins A2, B1 and B2) compared to the original batch. This research describes a robust mechanism for screening bioactive extracts for vascular effects. It also highlights batch variability as a significant limitation when using complex extracts for pharmacological activity, and suggests the use of in vitro systems as a tool to identify this problem in future studies.en_US
dc.language.isoenen_US
dc.rights© 2020 Elsevier. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.
dc.subjectBatch variabilityen_US
dc.subjectNitric oxideen_US
dc.subjectPlant extractsen_US
dc.subjectVascular functionen_US
dc.titlePhysiologically relevant screening of polyphenol-rich commercial preparations for bioactivity in vascular endothelial cells and application to healthy volunteers: A viable workflow and a cautionary taleen_US
dc.status.refereedYesen_US
dc.date.Accepted2019-12-10
dc.date.application2019-12-16
dc.typeArticleen_US
dc.type.versionAccepted manuscripten_US
dc.identifier.doihttps://doi.org/10.1016/j.bcp.2019.113754
dc.date.updated2020-04-29T12:28:34Z


Item file(s)

Thumbnail
Name:
jones_et_al_2020.pdf
Size:
1.103Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record